Navidea Biopharmaceuticals Company
Navidea Biopharmaceuticals is a leader in precision medicine with immuno-targeted products designed to help identify the sites.
Founded Date:
1983-01-01
Total Funding:
$92.5M
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
IPO
Technology:
Personalised Medicine
Last Funding Type:
Post-IPO Debt
Acquisitions Number:
1
Investors Number:
2
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Estimated Revenue:
Less than $1M